PPARα as a therapeutic target in inflammation-associated diseases

Author： Gervois Philippe Mansouri Roxane M

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.11, 2012-11, pp. : 1113-1125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2257-2262

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation-Associated Changes in Bone Homeostasis

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 3, 2012-06 ,pp. : 188-195

Bentham Science Publishers

Access to resources Recommend Favorite

Hydrogen sulfide as a therapeutic target for inflammation

By Rivers Jack R Badiei Alireza Bhatia Madhav

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 439-449

Informa Healthcare

Access to resources Recommend Favorite

Inflammation in Atherosclerosis: A New Therapeutic Target

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 283-295

Bentham Science Publishers

Access to resources Recommend Favorite

Proteases and their Receptors as Mediators of Inflammation-Associated Colon Cancer

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 2983-2992

Bentham Science Publishers

Access to resources Recommend Favorite